Concepedia

Lydia Bellmann

LB

Statistics

Publications

8

Citations

352

H-Index

8

Active since

2016

Affiliations

Universität Innsbruck(Current)

Innsbruck Medical University

Max Planck Institute of Colloids and Interfaces

Freie Universität Berlin

Lydia Bellmann is an author at Universität Innsbruck specializing in immunology, life sciences, and oncology.

Publications per year

2016–2021

8

Publications

8

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

Catherine Dold, Carles Urbiola, Guido Wollmann et al. · Molecular Therapy — Oncolytics · 2016 · 92 citations · Full text

Life Sciences, Immunology, Oncology +17

A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell Targeting

Eike‐Christian Wamhoff, Jessica Schulze, Lydia Bellmann et al. · ACS Central Science · 2019 · 92 citations · Full text

Medicine, Immunology, Oncology +11

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy

Christoph H. Tripp, Bart Tummers, Florian Hornsteiner et al. · Journal for ImmunoTherapy of Cancer · 2021 · 46 citations · Full text

Life Sciences, Immunology, Oncology +17

A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model

Lydia Bellmann, Giuseppe Cappellano, Johanna F. Schachtl‐Riess et al. · International Journal of Cancer · 2019 · 33 citations · Full text

Life Sciences, Immunology, Oncology +17

A Liposomal Platform for Delivery of a Protein Antigen to Langerin-Expressing Cells

Jessica Schulze, Mareike Rentzsch, Dongyoon Kim et al. · Biochemistry · 2019 · 28 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

1–5 of 8